164 related articles for article (PubMed ID: 30486930)
1. Toxicity Concerns of Therapeutic Nanomaterials.
Singla R; Sharma C; Shukla AK; Acharya A
J Nanosci Nanotechnol; 2019 Apr; 19(4):1889-1907. PubMed ID: 30486930
[TBL] [Abstract][Full Text] [Related]
2. Understanding the Factors Influencing Chitosan-Based Nanoparticles-Protein Corona Interaction and Drug Delivery Applications.
Moraru C; Mincea M; Menghiu G; Ostafe V
Molecules; 2020 Oct; 25(20):. PubMed ID: 33081296
[TBL] [Abstract][Full Text] [Related]
3. Toxicology of nanoparticles.
Elsaesser A; Howard CV
Adv Drug Deliv Rev; 2012 Feb; 64(2):129-37. PubMed ID: 21925220
[TBL] [Abstract][Full Text] [Related]
4. Fabricated nanoparticles: current status and potential phytotoxic threats.
Yadav T; Mungray AA; Mungray AK
Rev Environ Contam Toxicol; 2014; 230():83-110. PubMed ID: 24609519
[TBL] [Abstract][Full Text] [Related]
5. The ecotoxicology of nanoparticles and nanomaterials: current status, knowledge gaps, challenges, and future needs.
Handy RD; Owen R; Valsami-Jones E
Ecotoxicology; 2008 Jul; 17(5):315-25. PubMed ID: 18408994
[TBL] [Abstract][Full Text] [Related]
6. Structural parameters of nanoparticles affecting their toxicity for biomedical applications: a review.
Abbasi R; Shineh G; Mobaraki M; Doughty S; Tayebi L
J Nanopart Res; 2023; 25(3):43. PubMed ID: 36875184
[TBL] [Abstract][Full Text] [Related]
7. Surface engineering of inorganic nanoparticles for imaging and therapy.
Nam J; Won N; Bang J; Jin H; Park J; Jung S; Jung S; Park Y; Kim S
Adv Drug Deliv Rev; 2013 May; 65(5):622-48. PubMed ID: 22975010
[TBL] [Abstract][Full Text] [Related]
8. Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.
Bayda S; Hadla M; Palazzolo S; Riello P; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4269-4303. PubMed ID: 29284391
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of Nanomaterials: Using Nanotoxicology to Address the Safety Concerns of Nanoparticles.
Saifi MA; Khan W; Godugu C
Pharm Nanotechnol; 2018; 6(1):3-16. PubMed ID: 29065848
[TBL] [Abstract][Full Text] [Related]
10. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
Sant S; Poulin S; Hildgen P
J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249
[TBL] [Abstract][Full Text] [Related]
11. Impact of nanoparticles on human health and disease.
Roy B; Murugesan K; Mathanmohun M; Sathian B
Nepal J Epidemiol; 2023 Dec; 13(4):1294-1297. PubMed ID: 38299042
[TBL] [Abstract][Full Text] [Related]
12. A review on biogenic synthesis, applications and toxicity aspects of zinc oxide nanoparticles.
Sharma R; Garg R; Kumari A
EXCLI J; 2020; 19():1325-1340. PubMed ID: 33192216
[TBL] [Abstract][Full Text] [Related]
13. Silver Nanoparticles: Synthetic Routes, In Vitro Toxicity and Theranostic Applications for Cancer Disease.
De Matteis V; Cascione M; Toma CC; Leporatti S
Nanomaterials (Basel); 2018 May; 8(5):. PubMed ID: 29748469
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the toxicity of selected types of nanochemicals.
Kumar V; Kumari A; Guleria P; Yadav SK
Rev Environ Contam Toxicol; 2012; 215():39-121. PubMed ID: 22057930
[TBL] [Abstract][Full Text] [Related]
15. Overview on experimental models of interactions between nanoparticles and the immune system.
Najafi-Hajivar S; Zakeri-Milani P; Mohammadi H; Niazi M; Soleymani-Goloujeh M; Baradaran B; Valizadeh H
Biomed Pharmacother; 2016 Oct; 83():1365-1378. PubMed ID: 27580456
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticles toxicity and their routes of exposures.
Yah CS; Simate GS; Iyuke SE
Pak J Pharm Sci; 2012 Apr; 25(2):477-91. PubMed ID: 22459480
[TBL] [Abstract][Full Text] [Related]
17. Exocytosis of nanoparticles from cells: role in cellular retention and toxicity.
Sakhtianchi R; Minchin RF; Lee KB; Alkilany AM; Serpooshan V; Mahmoudi M
Adv Colloid Interface Sci; 2013 Dec; 201-202():18-29. PubMed ID: 24200091
[TBL] [Abstract][Full Text] [Related]
18. Immunotoxicological impact of occupational and environmental nanoparticles exposure: The influence of physical, chemical, and combined characteristics of the particles.
Pedata P; Petrarca C; Garzillo EM; Di Gioacchino M
Int J Immunopathol Pharmacol; 2016 Sep; 29(3):343-53. PubMed ID: 26684639
[TBL] [Abstract][Full Text] [Related]
19. Testing strategies to establish the safety of nanomaterials: conclusions of an ECETOC workshop.
Warheit DB; Borm PJ; Hennes C; Lademann J
Inhal Toxicol; 2007 Jun; 19(8):631-43. PubMed ID: 17510836
[TBL] [Abstract][Full Text] [Related]
20. New surface radiolabeling schemes of super paramagnetic iron oxide nanoparticles (SPIONs) for biodistribution studies.
Nallathamby PD; Mortensen NP; Palko HA; Malfatti M; Smith C; Sonnett J; Doktycz MJ; Gu B; Roeder RK; Wang W; Retterer ST
Nanoscale; 2015 Apr; 7(15):6545-55. PubMed ID: 25790032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
